Real World Estimate of Vaccination Protection in Individuals Hospitalized for COVID-19.

COVID-19 age anti-SARS-CoV-2 vaccination in-hospital death mechanical ventilation

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
01 Apr 2022
Historique:
received: 04 03 2022
revised: 29 03 2022
accepted: 30 03 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 24 4 2022
Statut: epublish

Résumé

Whether vaccination confers a protective effect against progression after hospital admission for COVID-19 remains to be elucidated. Observational study including all the patients admitted to San Paolo Hospital in Milan for COVID-19 in 2021. Previous vaccination was categorized as: none, one dose, full vaccination (two or three doses >14 days before symptoms onset). Data were collected at hospital admission, including demographic and clinical variables, age-unadjusted Charlson Comorbidity index (CCI). The highest intensity of ventilation during hospitalization was registered. The endpoints were in-hospital death (primary) and mechanical ventilation/death (secondary). Survival analysis was conducted by means of Kaplan-Meier curves and Cox regression models. Effect measure modification by age was formally tested. We included 956 patients: 151 (16%) fully vaccinated (18 also third dose), 62 (7%) one dose vaccinated, 743 (78%) unvaccinated. People fully vaccinated were older and suffering from more comorbidities than unvaccinated. By 28 days, the risk of death was of 35.9% (95%CI: 30.1−41.7) in unvaccinated, 41.5% (24.5−58.5) in one dose and 28.4% (18.2−38.5) in fully vaccinated (p = 0.63). After controlling for age, ethnicity, CCI and month of admission, fully vaccinated participants showed a risk reduction of 50% for both in-hospital death, AHR 0.50 (95%CI: 0.30−0.84) and for mechanical ventilation or death, AHR 0.49 (95%CI: 0.35−0.69) compared to unvaccinated, regardless of age (interaction p > 0.56). Fully vaccinated individuals in whom vaccine failed to keep them out of hospital, appeared to be protected against critical disease or death when compared to non-vaccinated. These data support universal COVID-19 vaccination.

Identifiants

pubmed: 35455299
pii: vaccines10040550
doi: 10.3390/vaccines10040550
pmc: PMC9031136
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : HORIZON-HLTH-2021-CORONA-01
ID : 101046016

Références

MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(4):139-145
pubmed: 35085224
Lancet. 2021 Dec 4;398(10316):2093-2100
pubmed: 34756184
Nature. 2021 Dec;600(7888):197-199
pubmed: 34857948
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Lancet. 2022 Jan 29;399(10323):437-446
pubmed: 35065011
Clin Microbiol Infect. 2022 Jun;28(6):871-878
pubmed: 35219807
MMWR Morb Mortal Wkly Rep. 2021 Sep 17;70(37):1284-1290
pubmed: 34529637
N Engl J Med. 2021 Dec 23;385(26):2413-2420
pubmed: 34879190
Cancer Invest. 1992;10(6):525-31
pubmed: 1422890
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Lancet. 2021 Jan 9;397(10269):99-111
pubmed: 33306989
N Engl J Med. 2021 Jun 10;384(23):2187-2201
pubmed: 33882225
JAMA. 2021 Nov 23;326(20):2043-2054
pubmed: 34734975
Life (Basel). 2021 Sep 17;11(9):
pubmed: 34575128
Int J Infect Dis. 2020 Nov;100:67-74
pubmed: 32950738
BMC Infect Dis. 2020 Nov 27;20(1):897
pubmed: 33246431
Environ Res. 2021 Apr;195:110777
pubmed: 33485909
BMJ. 2021 Dec 23;375:n3144
pubmed: 34949600
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Nature. 2021 Dec;600(7890):577-578
pubmed: 34934198
Lancet Infect Dis. 2021 Nov;21(11):e342-e347
pubmed: 34019801
Euro Surveill. 2021 Nov;26(47):
pubmed: 34823641
N Engl J Med. 2021 Dec 23;385(26):2487-2489
pubmed: 34818474
Lancet Public Health. 2020 Jun;5(6):e310
pubmed: 32339478
Ann Epidemiol. 2021 May;57:14-21
pubmed: 33662494

Auteurs

Antonella d'Arminio Monforte (A)

Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.

Alessandro Tavelli (A)

Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.

Sara De Benedittis (S)

Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.

Francesca Bai (F)

Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.

Camilla Tincati (C)

Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.

Lidia Gazzola (L)

Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.

Ottavia Viganò (O)

Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.

Marina Allegrini (M)

Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.

Debora Mondatore (D)

Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.

Daniele Tesoro (D)

Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.

Diletta Barbanotti (D)

Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.

Giovanni Mulé (G)

Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.

Roberto Castoldi (R)

Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.

Anna De Bona (A)

Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.

Teresa Bini (T)

Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.

Davide Chiumello (D)

Intensive Care Unit ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.

Stefano Centanni (S)

Pneumology Unit ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.

Sabrina Passarella (S)

Medical Direction ASST Santi Paolo e Carlo, 20142 Milan, Italy.

Nicola Orfeo (N)

Medical Direction ASST Santi Paolo e Carlo, 20142 Milan, Italy.

Giulia Marchetti (G)

Unit of Infectious Diseases ASST Santi Paolo e Carlo, Department of Health Sciences, University of Milan, 20142 Milan, Italy.

Alessandro Cozzi-Lepri (A)

Institute for Global Health, University College London, London NW3 2PF, UK.

Classifications MeSH